文献速递外周动脉疾病

下肢冷冻保存大隐静脉旁路移植血管瘤样变性的管理

The Management of Aneurysmal Degeneration of Lower Extremity Cryopreserved Saphenous Vein Bypass Grafts.
PubMed 文献 · Ann Vasc Surg · 2024-04-06

本病例系列回顾性分析2001至2021年间一家三级社区中心植入的冷冻保存大隐静脉旁路移植血管,17条移植物(13例患者)出现无感染的瘤样变性;多数动脉瘤位于移植物体部而非吻合口,13条行开放手术、3条行覆膜支架腔内修复,保肢率87%,修复后1年持续通畅率65%。

要点

  • 冷冻保存大隐静脉旁路移植血管可发生瘤样变性,本组17条移植物均无感染。
  • 瘤样变性多位于移植物体部(13条),距初次手术至首次因瘤样改变修复平均4年。
  • 本组保肢率87%,修复后持续通畅率6个月79%、1年65%、3年54%、5年27%。

核心结论

  • 作者经验中冷冻保存大隐静脉移植血管的瘤样变性多采用标准开放手术处理,腔内治疗也可接受;本组保肢率与修复后1年持续通畅率可接受,病例系列强调对冷冻保存大隐静脉患者进行严密监测的重要性。

研究设计与样本

  • 回顾性病例系列,纳入本机构2001至2021年间因下肢旁路植入且有瘤样改变证据的全部冷冻保存大隐静脉,排除有活动性感染证据者,是否干预由术者决定。
  • 共识别13例患者的17条旁路移植血管在无感染情况下发生瘤样变性。

主要发现

  • 13例患者中9例为男性,初次手术时平均年龄72岁、平均体重指数28。
  • 初次旁路指征包括急性肢体缺血9条、腘动脉瘤2条、慢性肢体威胁性缺血Rutherford IV级5条和V级1条。
  • 初次手术至首次因瘤样改变行移植物修复的平均时间为4年,13条动脉瘤发生于移植物体部而非吻合口部位。
  • 13条移植物行开放手术处理,3条行腔内技术处理,所有腔内修复均通过覆膜支架完成。
  • 从初次旁路起平均随访7年、从末次瘤样修复起平均随访2年;本队列保肢率为87%,2条肢体需截肢且均曾行开放重建;本系列死亡率为54%,无患者死于移植物并发症。

临床怎么用

  • 作者认为冷冻保存大隐静脉移植血管瘤样变性多可采用标准开放手术技术处理,腔内治疗也可接受。
  • 作者指出本病例系列强调对冷冻保存大隐静脉患者进行严密监测的重要性。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The use of cryopreserved saphenous veins (CSVs) for the treatment of lower extremity peripheral arterial disease is an attractive option when there is no available autogenous vein. Prior studies found CSVs are at risk for aneurysmal degeneration requiring reoperation. As the management of these complications and patient outcomes is not well described, the objective of this case series is to describe the open and endovascular management of degenerative CSVs at a tertiary community center. METHODS: All CSVs implanted for lower extremity bypass at our institution between 2001 and 2021 were retrospectively reviewed. All CSVs with evidence of aneurysmal change were included in this study. CSVs with evidence of active infection were excluded. The decision to intervene was left to the discretion of the operating surgeon. Demographic data, indications for the index operation, and details about subsequent interventions for degenerative CSVs were recorded. Study end points included limb salvage and continued patency. Demographic data, indications for the index operation, and details about subsequent interventions for degenerative CSVs were recorded. RESULTS: Seventeen bypasses were identified to have aneurysmal degeneration in 13 patients in the absence of infection between 2001 and 2021. Nine of the 13 patients were male, and the average age and body mass index during the index procedure were 72 and 28, respectively. Indications for the index bypass included acute limb ischemia (9), popliteal aneurysm (2), and chronic limb threatening ischemia with Rutherford's class IV (5) and V (1). The mean time between the index procedure and first graft revision due to aneurysmal changes was 4 years. Most of the aneurysms did not occur at the site of anastomosis with 13 occurring in the body of the graft. Thirteen grafts were managed with open surgery and 3 were managed with endovascular techniques. All endovascular repairs were managed via covered stenting. Patients were followed for an average duration of 7 years from the initial bypass and 2 years from their last aneurysmal repair. Limb salvage in this cohort was 87% with 2 limbs requiring amputation, all of whom underwent open reconstruction. The mortality rate in this series was 54% and no patients died due to complications from their graft. Continued patency on Kaplan Meier survival curve analysis was 79% at 6 months, 65% at 1 year, 54% at 3 years, and 27% at 5 years. CONCLUSIONS: In our experience, aneurysmal degeneration of CSV grafts was mostly managed with standard open surgical techniques, although endovascular therapy also proved acceptable. Limb salvage rates and continued patency of repair at 1 year in this cohort were acceptable. This case series highlights the importance of diligent surveillance for patients with CSVs.

来源:Ann Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Li R, Magliochetti Cammarata TM, Gasienica J, et al. The Management of Aneurysmal Degeneration of Lower Extremity Cryopreserved Saphenous Vein Bypass Grafts. Ann Vasc Surg. 2024. PMID: 38588956. doi:10.1016/j.avsg.2024.02.002

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。